Author Information
Gregory J. Mertz is a distinguished researcher affiliated with the Division of Infectious Diseases, Department of Internal Medicine at the University of New Mexico in Albuquerque, New Mexico. His work primarily focuses on infectious diseases, contributing significant insights into various viral infections, including hantavirus and SARS-CoV-2.Research Contributions
Gregory J. Mertz has made substantial contributions to the field of infectious diseases, with a particular emphasis on viral pathogens such as hantaviruses and SARS-CoV-2. In 2021, his research included studies on the transcriptomic signatures of Hantavirus Cardiopulmonary Syndrome, tracing Sin Nombre Virus transmission, and exploring proteinuria as a mortality-linked finding in Hantavirus Cardiopulmonary Syndrome. Additionally, his work explored the efficacy of combining interferon beta-1a with remdesivir in treating hospitalized COVID-19 patients. In 2020, Mertz investigated COVID-19-related complications such as QTc prolongation, neutralizing antibody titers in convalescent plasma, and the effectiveness of different assays in measuring anti-Andes orthohantavirus antibodies.Aliases
Gregory J. Mertz is known by several aliases in academic and research circles, including G. J. Mertz, Greg Mertz, and G Mertz. These variations are often used interchangeably in publications and citations.Publication and Citation Metrics
| Metric |
Value |
| Citation Count |
5430 |
| H-Index |
38 |
| Paper Count |
100 |
